Abstract
This paper reviews and evaluates all the published QSAR treatments of LOX inhibitors. This reveals that in almost all cases, the clog P parameter plays an important part in the QSAR relationships. In some cases the steric factors (B1, B5 and L) as well as the overall molar refractivity (CMR) or the substitutents molar refractivity (MR) are important. Electronic effects except for the Hammets constant θ, are comparatively unimportant. The study shows that log P as calculated from the Clog P program is suitable for this form of QSAR study. Log Po of 2.77-3.76 was found to be ideal, for the biological response.
Keywords: qsar, lox inhibitors, lipophilicity, steric factors, electronic effects
Mini-Reviews in Medicinal Chemistry
Title: Review in Quantitative Structure Activity Relationships on Lipoxygenase Inhibitors
Volume: 3 Issue: 5
Author(s): Pontiki Eleni and Hadjipavlou-Litina Dimitra
Affiliation:
Keywords: qsar, lox inhibitors, lipophilicity, steric factors, electronic effects
Abstract: This paper reviews and evaluates all the published QSAR treatments of LOX inhibitors. This reveals that in almost all cases, the clog P parameter plays an important part in the QSAR relationships. In some cases the steric factors (B1, B5 and L) as well as the overall molar refractivity (CMR) or the substitutents molar refractivity (MR) are important. Electronic effects except for the Hammets constant θ, are comparatively unimportant. The study shows that log P as calculated from the Clog P program is suitable for this form of QSAR study. Log Po of 2.77-3.76 was found to be ideal, for the biological response.
Export Options
About this article
Cite this article as:
Eleni Pontiki and Dimitra Hadjipavlou-Litina, Review in Quantitative Structure Activity Relationships on Lipoxygenase Inhibitors, Mini-Reviews in Medicinal Chemistry 2003; 3 (5) . https://dx.doi.org/10.2174/1389557033487999
DOI https://dx.doi.org/10.2174/1389557033487999 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Early Involvement of the Innate Immunity in the Pathogenesis of Lateonset Alzheimers Disease: Neuropathological, Epidemiological and Genetic Evidence
Current Alzheimer Research Alterations of Sex Differentiation in Males: From Candidate Genes to Diagnosis and Treatments
Current Pharmaceutical Design QSAR Analysis of Some Antagonists for p38 map kinase Using Combination of Principal Component Analysis and Artificial Intelligence
Combinatorial Chemistry & High Throughput Screening An Overview of the Pharmacological Properties and Potential Applications of Natural Monoterpenes
Mini-Reviews in Medicinal Chemistry Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway
Current Cancer Drug Targets Viral Protein Functions Study by Affinity Modification
Mini-Reviews in Medicinal Chemistry Recent Progress in Machine Learning-based Prediction of Peptide Activity for Drug Discovery
Current Topics in Medicinal Chemistry Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Molecular Genetics of Polycystic Ovary Syndrome: An Update
Current Molecular Medicine Intracellular Signaling Triggered by Formyl-Peptide Receptors in Nonphagocytic Cells
Current Signal Transduction Therapy Vascular Effects of Ambient Pollutant Particles and Metals
Current Vascular Pharmacology p53-Induced Apoptosis and Inhibitors of p53
Current Medicinal Chemistry Erythropoietin Gene Polymorphism rs551238 is Associated with a Reduced Susceptibility to Brain Injury in Preterm Infants
Current Neurovascular Research Molecular Pharmacology of the Glycine Receptor Chloride Channel
Current Pharmaceutical Design Emerging Promise of Immunotherapy for Alzheimer’s Disease: A New Hope for the Development of Alzheimer’s Vaccine
Current Topics in Medicinal Chemistry A Critical Approach of Guideline Therapeutic Recommendations for NAFLD
Current Vascular Pharmacology Inhibitory Smad7: Emerging Roles in Health and Disease
Current Molecular Pharmacology Protease-Activated Receptors (PARs) are Partly Pro-Inflammatory and Partly Anti-Inflammatory: Will PAR Agonists or Antagonists Participate in Future Drug Therapies?
Current Drug Targets Inhibition of Early Upstream Events in Prodromal Alzheimer’s Disease by Use of Targeted Antioxidants
Current Aging Science The Possible Use of Terpene Compounds in DC Immunotherapy against Cancer
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)